Posts in category All News
Bihar polls to be held in 5 phases, starting Oct 12 through Nov 5 (09-09-2015)
Telecom stocks gain after govt clears spectrum trading guidelines; RComm surges over 12% (09-09-2015)
The Cabinet cleared spectrum trading guidelines on Wednesday under which telecom operators will be able to sell radiowaves to other service providers, a move that will help address the problem of spectrum shortage.
Cheering the announcement, share price of Reliance Communication surged 12.47 per cent to Rs 62.70, followed by Bharti Airtel and Idea Cellular which gained 2.55 per cent and 3.01 per cent at Rs 355.60 and Rs 150.50, respectively in the afternoon trade. Sensex was up 411 points at 25,730.
“Cabinet has approved spectrum trading today. Telecom sector has been demanding it for optimum utilisation of spectrum,” Telecom Minister Ravi Shankar Prasad said.
As of now only government is allowed to allocate spectrum to telecom firms through auctions.
The decision move is expected to increase efficient use of radiowaves by enabling telecom operators, who have a low subscriber base or unutilised spectrum lying with them, to trade in radiowaves.
(With inputs from PTI)
Cabinet clears gold bond, monetisation schemes (09-09-2015)
Syngene International IPO – Views invited (09-09-2015)
If venturing into commercial manufacturing is successful, then 5 years post start of commercial manufacturing, opportunity could be huge for this company.....It will not be right to put any number to it but one can gauge the size from the fact that industry itself is likely to grow in double digits in foreseeable future.
Getting associated with an innovator for NME takes atleast 8-10 years of trust building....forget here the high quality standards you need to maintain and multiple inspections that you need to clear not only from regulatory authorities but also from the innovator.
Just wait for Sep.'15 shareholding vivek, its not far away.....we might find good institutional holding in that shareholding disclosure. With rgds. to Columbia Pacific, you can find its details on https://www.columbiathreadneedleus.com ....its heartening to see the fund investing more than 3 % of its corpus in Syngene......the fund seems to be a long term investor with many bluechip names in its holding....
Rgds.
Vakrangee (09-09-2015)
Already got nod for 100% FDI in white label ATMs, whats the impact with Vakrangee
Thanks
Syngene International IPO – Views invited (09-09-2015)
@Mahesh I like both Syngene and Suven - both would be among my top 6-7 bets (if I was forced to take 6-7 bets). With Syngene, what I like more is that they are involved from discovery stage for many molecules. With Suven, what I like is that they have mind-blowing margins for CRM (ex their in-house research); inspite of their cash guzzling research, and assuming none of this fructifies, I still believe Suven is a very good business. If one wants to take the inhouse research into consideration for valuation, then I agree - Suven has no place in a concentrated portfolio. Syngene I feel is slightly overvalued at CMP, Suven is fairly valued.
@Vivek_6954 As Mahesh has mentioned, the 3 phases of clinical trials take 6-8 years, not even considering the discovery phase. So if a company enters this business today and if they get small contracts, the partner might see that they are doing good work after few years, but to build trust about privacy with the partner, and particularly in the industry would take a longer time. The other aspect is one would need to start with smaller number of scientists and increase as one gets more contracts. One can poach a handful of experienced scientists here-there but not a team as large as Syngene.
Q for scuttlebutt: How satisfied are the scientists at Syngene/Suven with their careers?
Discl.: No holding in Syngene or Suven. Recently sold off stake in Suven on realizing mistake that there is no MoS.